Cytek Biosciences director Michael Holder receives 2,181 shares as restricted stock units vest
CTKB•Director Michael Holder received 2,181 Cytek Biosciences common shares when restricted stock units vested on Nov. 18, 2026. After the transaction, he directly owned 65,056 common shares and 5,095 restricted stock units.
1. Shares received
Michael Holder received 2,181 Cytek Biosciences common shares from restricted stock units on Nov. 18, 2026. Following the transaction, he directly owned 65,056 common shares and 5,095 restricted stock units.




